KBC Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-565
Closed -$28K 1889
2024
Q1
$28K Buy
+565
New +$28K ﹤0.01% 1786